GCLCi0
GCLCi0 (ONO-6428513) is a glutamate-cysteine ligase catalytic subunit (GCLC) inhibitor and ferroptosis inducer that blocks the rate-limiting step of glutathione synthesis and exerts anti-tumor activity. GCLCi0 specifically targets SMARCB1-deficient cancer cells, induces reactive oxygen species production and lipid peroxidation. In addition, GCLCi0 shows a significant synergistic effect with SLC7A11 inhibitors and Telaglenastat (HY-12248). GCLCi0 can be used in the research of smarcb1-deficient malignant rhabdoid tumors and smarcb1-deficient epithelioid sarcomas.
For research use only. We do not sell to patients.
- CAS No.: 2926699-71-8
- Formula: C8H15F3N2O3S
- Molecular Weight:276.28
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2926699-71-8
-
Molecular Weight 276.28
-
Formula C8H15F3N2O3S
-
SMILES
N[C@H](C(O)=O)CCS(=N)(CCCC(F)(F)F)=O
-
Synonyms
ONO-6428513
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- GCLCi0
- 2926699-71-8
- ONO-6428513
- GCLCi 0
- GCLCi-0
- ONO6428513
- ONO 6428513
- Ferroptosis
- ferroptotic cell death
- reactive oxygen species
- epithelioid sarcomas
- JMU-RTK-2
- malignant rhabdoid tumors
- glutathione synthesis
- mouse tumor xenograft models
- glutamate-cysteine ligase catalytic subunit
- lipid peroxidation
- SMARCB1-deficient cancer cells
- Inhibitor
- inhibitor
- inhibit